Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

• James J. Harding
• , Sarina A. Piha-Paul
• , Ronak H. Shah
• , Jessica J. Murphy
• , James M. Cleary
• , Geoffrey I. Shapiro
• , David I. Quinn
• , Irene Braña
• , Victor Moreno
• , Mitesh Borad
• , Sherene Loi
• , Iben Spanggaard
• , Haeseong Park
• , James M. Ford
• , Mónica Arnedos
• , Salomon M. Stemmer
• , Christelle de la Fouchardiere
• , Christos Fountzilas
• , Jie Zhang
• , Daniel DiPrimeo
• , Casey Savin
• , S. Duygu Selcuklu
• , Michael F. Berger
• , Lisa D. Eli
• , Funda Meric-Bernstam
• , Komal Jhaveri
• , David B. Solit
• , Ghassan K. Abou-Alfa